2017 International Congress Archives - Page 53 of 155

Pain and Parkinson’s disease

H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)
Pairing TMS and physical therapy for treatment of gait and balance disorders in Parkinson’s Disease: a randomized pilot trial

A. Cucca, H. Migdadi, T. Biller, S. Agarwal, P. Kumar, A. Son, M. Ko, E. Gallo, S. Fisher, A. Di Rocco, M. Biagioni (New York, NY, USA)
Palliative Care in Parkinson Disease

A. Patterson, L. Almeida, M. Okun, I. Malaty (Gainesville, FL, USA)
Palmaris Brevis Spasm:A rare cause of paediatric movement disorder

T. Yeo, A. Yacoob (Singapore, Singapore)
Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)
Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease

A. Ivashynka, S. Likhachev (Minsk, Belarus)
Parkinson ‘ s disease and Peripheral Nervous System : Wax and Waning Non-motor offs and Levodopa-use Topics

s.g. echebarria mendieta (-, Spain)
Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?

M. Rosso, A. Merola, A. Romagnolo, C. Comi, A. Fasano, M. Zibetti, R. Lopez-Castellanos, D. Cocito, L. Lopiano, A. Espay (Cincinnati, OH, USA)
Parkinson Syndrome associated with inositol-1,4,5-triphosphate receptor antigen type 1 (ITPR1) antibodies

B. Wimmer, K. Fuchs, U. Bogdahn, A. Heimeroth (Regensburg, Germany)
Parkinson’s Disease and Urogenital Dysfunction

N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)
Parkinson’s disease disrupts motor skill learning that requires improvement of a speed-accuracy trade-off

C. Kim, A. Zimnik, U. Kang, P. Mazzoni (New York, NY, USA)
Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)
Parkinson’s disease patients with cognitive impairment more sensitive to pain?

K. Abe, K. Fukushima, K. Ando, Y. Maeda, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)
Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)
Parkinson’s disease and comorbidity: A US national perspective

A. Mithal, B. Lingala, A. Niyazov, A. Guo, C. Marras, G. Singh (Woodside, CA, USA)
Parkinson’s disease and progressive dysphagia – consider myasthenia gravis

P. Urban (Hamburg, Germany)
Parkinson’s Disease from the Patient Perspective

L. Mischley, G. Canada, R. Lau (Kenmore, WA, USA)
Parkinson’s disease GWAS risk loci and symptom progression

K. Paul, J. Schulz, J. Bronstein, C. Lill, B. Ritz (los angeles, CA, USA)
Parkinson’s Disease Medications Availability in Each Philippine Region

S. Villaraza, C. Go (Manila, Philippines)
Parkinson’s disease phenotype across different ethnic groups: Comparison of non-motor symptoms in patients living in the United Kingdom and Mexico

A. Sauerbier, M. Rodriguez Violante, A. Cervantes Arriaga, A. Rizos, D. Trivedi, P. Martinez-Martin, M. Parry, M. Rosa-Grilo, R. Brown, K. Ray Chaudhuri (London, United Kingdom)
Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

M. Miyata, S. Kakeda, T. Yoneda, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)
Parkinson’s Disease-Like Pathology in the Rat Brain and Colon Following Methamphetamine Self-Administration

B. Bradaric, A. Persons, S. Kousik, L. Kelly, S. Graves, T.C. Napier (Chicago, IL, USA)
Parkinsonian Features in a Cohort of Gaucher’s Disease (GD) Patients and Relatives.

I. Trezzi, E. Monfrini, G. Buongarzone, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappellini, A. Di Fonzo (Milan, Italy)
Parkinsonics – A Prospective, Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Non-Motor Symptoms in Idiopathic Parkinson Disease (PD)

A. Butala, A. Swaminathan, S. Dunlop, Y. Salnikova, B. Ficek, B. Portnoff, M. Harper, B. Vernon, Z. Mari, A. Pantelyat (Baltimore, MD, USA)
Parkinsonism in Human African Trypanosomiasis: Clinical course, imaging findings and treatment-related challenges.

A. Aggarwal, T. Singhal, P. Borade, L. Hachaambwa, M. Munshi, D. Sanghvi, P. Dutta, A. Shrivastava (Mumbai, India)
Parkinsonism in Patients with Alzheimer Disease and Epileptic Seizures

I. Petrov (Skopje, The former Yugoslav Republic of Macedonia)
Parkinsonism in the very old – A clinicopathological study

A. Rajput, E. Rajput (Saskatoon, SK, Canada)
Parkinsonism Revealing Cerebral Hematoma with Moya Moya Disease

z. brahem, i. bedoui, a. riahi, m. mansour, j. zaouali, r. mrissa (tunis, Tunisia)
Parkinsonism through astrocytic GABA induce motor symptoms

M.J. Lee, Y. Jang, J. Han, S.J. Kim, J. Kim, I. Ryu, X. Ju, M.J. Ryu, S.-Y. Choi, G.R. Kweon (Daejeon, Republic of Korea)
Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease

M. Wolf, M. Abdallat, C. Blahak, J. Krauss (Mannheim, Germany)
Pathway Selective Deep Brain Stimulation Derived from Patient-Specific Models

K. Gunalan, B. Howell, R. Patriat, Y. Duchin, G. Sapiro, N. Harel, C. McIntyre (Cleveland, OH, USA)
Patient characteristics that impact caregiver burden in Parkinson’s disease in Singapore

K. Prakash, E.-K. Tan (Singapore, Singapore)
Patient characteristics vary by DBS indication in Parkinson disease patients

A. Pusso, S. Sperling, M. Harrison, F. Wooten, J. Elias, B. Shah, M. Barrett (Charlottesville, VA, USA)
Patient Clustering through a Mobile-based PD Severity Score

A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)
Patient Engagement in Parkinson’s Research: A Comparison of Attitudes and Impact in the UK and the US

V. Todaro, C. Nolan, K. Schroeder, I. Abbey-Vital, M. Feeney (New York, NY, USA)
Patient perspectives of using the ND0612 mini-pump

S. Nash, M. Gera, E. Shor, T. Rachmilewitz Minei, S. Oren (Rehovot, Israel)
Patient-derived GBA1-PARK2 double-mutant cellular models to study the effect of GBA1 as a modifier of familial Parkinson’s disease

Z. Hanss, I. Boussaad, P. Barbuti, S. Goldwurm, R. Krüger (Belvaux, Luxembourg)
Patient-reported hallucinations and the probability of progression to dementia in Parkinson’s disease

K.-L. Horne, D. Myall, M. MacAskill, L. Livingston, S. Grenfell, T. Melzer, T. Pitcher, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)
Patient-Reported Outcomes in a Prospective Real-World Study of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension

S. Kymes, C. François, K. McLeod, A. Duhig, A. Ogbonnaya, A. Quillen, J. Cannon, C. Shibao, B. Yue, I. Biaggioni (Deerfield, IL, USA)
Patients affected by functional motor symptoms are not liars: an experimental deception study with the Guilty Knowledge Task

B. Demartini, R. Ferrucci, D. Goeta, F. Ruggiero, A. Priori, O. Gambini (Milano, Italy)
Patients with Essential Tremor Live Longer than their Relatives

C. Akbostanci, K. Doğanyiğit, M. Şen, E. Onat, A. Tekinay, T. Özçelik, M. Akbostanci (Snoqualmie, WA, USA)
Patients’ Perspective of Physicians’ Counseling on Exercise in Parkinson’s Disease (PD)

J.Y. Park, V. Shanker (New York, NY, USA)
Pattern and Predictors Of Tremor In Patients With Primary Dystonia

R. Rajan, S. Zafer, S. Krishnan, A. Kishore (Trivandrum, India, India)
Pattern of MRI findings in ephedronic encephalopathy

M. Okujava, F. Todua, M. Janelidze, I. Khatiashvili (Tbilisi, Georgia)
Patterns of Striatal DAT Binding Loss in a Progressing Parkinson Disease (PD) Cohort: Four year PPMI Follow-up

J. Seibyl, K. Marek (New Haven, CT, USA)
PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins

A. Perez-Soriano, J. Arena, V. Sossi, K. Dinelle, Q. Miao, J. McKenzie, N. Neilson, A. Puschmann, P. Schaffer, H. Shinotoh, J. Smith-Forrester, E. Shahinfard, N. Vafai, D. Wile, Z. Wszolek, M. Higuchi, A.J. Stoessl (Vancouver, BC, Canada)
PD Check-In: Supporting people with Parkinson’s Disease in self-managed maintenance of communication following intensive speech treatment

A. Finnimore, D. Theodoros, A. Rumbach (Brisbane, Australia)
PDSS: A Novel Mobile-based Parkinson Disease Severity Score

A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)
Perceived facilitators and barriers in communicating with family member among people with Parkinson’s Disease: A focus group study

J. Lee, Y. Kim (Seoul, Republic of Korea)
Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality

J. Hinkle, K. Perepezko, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)
Perceptual and acoustical analysis of speech in multiple system atrophy and progressive supranuclear palsy.

S. Contardi, A. Gessani, F. Cavallieri, C. Budriesi, A. Bernardi, M. Tondelli, E. Menozzi, A. Chiari, P. Nichelli, F. Valzania (Modena, Italy)
Perceptual decision making and reflection impulsivity in drug naïve and treated patients with restless legs syndrome

B. Heim, M.-T. Pertl, A. Stefani, A. Heidbreder, L. Zamarian, E. Brandauer, B. Averbeck, M. Delazer, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)
Perrault syndrome: CLPP-Knock-Out mouse brain shows accumulation of mitoribosomes

J. Key, J. Heidler, S. Torres-Odio, G. Auburger, I. Wittig, S. Gispert (Frankfurt am Main, Germany)
Persistent L-Dopa Responsive Hemiparkinsonism After Cryptococcoal Meningoencephalitis in an Immunocompetent Man

G. Fabiani, R. Filho, F. Germiniani, H. Teive (Curitiba, Brazil)
Personal KinetiGraph (PKG) for Parkinson’s Disease: Experience at a Tertiary Care Center

V. Sharma, A. Fowler, K. Lyons, R. Pahwa (Kansas City, KS, USA)
Personal KinetiGraph Devices Assessing Efficacy of Continuous Enteral Carbidopa/Levodopa Infusion Therapy

J. Margolesky, C. Luca (Miami, FL, USA)
PET-MRI Imaging in Parkinson Dementia Complex of Guam: A Case Report

A. Tran, K. Chan, V. Kharidi, E. Goldstein, R. Burns, P. Reyes (Phoenix, AZ, USA)
Pharmacokinetic profile of continuous levodopa/carbidopa delivery when administered subcutaneously (ND0612) versus duodenal infusion (levodopa/carbidopa intestinal gel)

L. Adar, T. Rachmilewitz Minei, Y. Cohen, S. Oren (Rehovot, Israel)
Pharmacological modulation of mGluR5 improves dyskinesias mediated by D1 but not D2 receptor stimulation.

I. Sebastianutto, N. Maslava, L. Di Menna, F. Nicoletti, M. Cenci (Lund, Sweden)
Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)
Phasic activity during non REM sleep

R. Miguel, I. Arnulf (Lisboa, Portugal)
Phenotype of PLP1-related disorder caused by novel mutation: a case report

N. Kresojevic, I. Petrovic, V. Dobricic, A. Tomic, M. Svetel, V. Kostic (Belgrade, Serbia)
Phenotypic Heterogeneity in PSP Variants – A Case Series

S. BHADRAN, S. ABRAHAM, B. NATARAJAN, A. MEKKATTUKUNNEL, J. KRISHNAN, R. ISAAC, P.K. PAL (THRISSUR, India)
Phosphodiesterases and striatal pathways in Parkinson’s disease

H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, A. Tziortzi, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)
Physical Activity and Quality of Life in People with Parkinson’s Disease – A Long-term Follow-up Study

I-F. Shih, K. Paul, J. Bronstein, B. Ritz (Los Angeles, CA, USA)
Physical activity habits in early Parkinson’s disease and healthy controls

A. Amara, N. Seedorff, L. Chahine, K. Kieburtz, C. Caspell-Garcia, T. Simuni (Birmingham, AL, USA)
Physical Activity in Early Parkinson Disease

S. Mantri, M. Fullard, J. Duda, J. Morley (Philadelphia, PA, USA)
Physical and cognitive stimulation through environmental enrichment prevents early molecular pathology in a Parkinson´s disease model

Z. Wassouf, T. Hentrich, S. Samer, O. Riess, N. Casadei, J. Schulze-Hentrich (Tübingen, Germany)
Physical but not mental aspects of health-related quality of life are improved in 10-year long-term follow-up of deep brain stimulation for segmental dystonia

C. Blahak, M. Wolf, A. Saryyeva, H. Baezner, J. Krauss (Mannheim, Germany)
Physical Mobility Predictors and the Bone Health in Parkinson’s Disease

L. LEANDRO, C. MOREIRA, H. TEIVE (Curitiba, Brazil)
Pilot evaluation of pseudoelastic orthoses for supporting motor control in children with secondary dystonia and dyskinesia

L. Garavaglia, E. Pagliano, M.T. Arnoldi, R. Zanin, M.A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)
Piper betle L. Attenuates 6-OHDA Induced Apoptosis in SH-SY5Y Cells and Neuronal Injury in Caenorhabditis elegans Parkinson’s Model

G. Shanmugam, A. Mohankumar, P. Sundararaj (Coimbatore, India)
Piperine potentiate the neuroprotective effect of quercetin against MPTP induced neurotoxicity in rats

S. Singh, P. Kumar (Moga, India)
Plasma Biomarkers in Idiopathic Normal Pressure Hydrocephalus

P.-W. Ko, K. Kang, S.Y. Kim, H.-W. Lee (Daegu, Republic of Korea)
Polyneuropathy in patients with Parkinson’s disease from southern Spain treatment with levodopa/carbidopa intestinal gel infusión

F. Carrillo, S. Jesus, L. Vargas, M. Bernal, M.T. Caceres, A.D. Adarmes, M. Carballo, P. Mir (Seville, Spain)
Post-hoc analyses of the recommended starting dose for Rytary based on “off” time

N. Modi, S. Khanna, S. Gupta (Hayward, CA, USA)
Post-movement beta rebound inhibits future movement

E. Rhodes, A. Kharko, W. Gaetz, S. Hall (Plymouth, United Kingdom)
Postoperative Cognitive Impairment Following Deep Brain Stimulation Surgery

A. Whyte-Rayson, P. Hickey, M. Berger (Durham, NC, USA)
Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease

F. Sasaki, G. Oyama, M. Ito, S. Sekimoto, R. Nakamura, T. Jo, Y. Simo, A. Umemura, N. Hattori (Tokyo, Japan)
Postural control is maintained after a 8-months period of exercise in people with Parkinson’s disease

L. Gobbi, N. Rinaldi, P. Pelicioni, E. Lirani-Silva, L. Moraes, M. Pereira (Rio Claro, Brazil)
Postural Instability is a Predictor for Driving Cessation Among Parkinson’s Disease Drivers: A Study of a Computer-Based 3D Driving Simulator.

O. Jitkritsadakul, S. Krootjohn, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)
Potential of non-invasive brain stimulation to ameliorate freezing of gait in Parkinson’s disease: A deep repetitive TMS randomized, double-blinded, cross-over pilot study

M. Dagan, T. Herman, A. Mirelman, N. Giladi, J. Hausdorff (Tel Aviv, Israel)
Potential preclinical gait and balance markers for developing Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)

J. O'Keefe, E. Robertson, A. McAsey, M. Swanson, C. Huml, E. Berry-Kravis, D. Hall (Chicago, IL, USA)
Pre-synaptic dopaminergic deficit in a patient with familial FTD

M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)
Predict Cognitive Decline with Clinical Markers in Parkinson’s Disease

G. Pagano, T. Yousaf,, C. Loane, S. Polychronis, H. Wilson, B. Giordano, F. Niccolini, M. Politis (London, United Kingdom)
Predict cognitive decline with non-clinical markers in Parkinson’s disease

T. Yousaf, G. Pagano, F. NIccolini, M. Politis (London, United Kingdom)
Predicting the onset of freezing of gait: A longitudinal study

K. Ehgoetz Martens, E. Lukasik, M. Georgiades, M. Gilat, J. Hall, C. Walton, S. Lewis (Camperdown, Australia)
Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures

C. Nazor, C. Zabetian, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, S.-C. Hu, T. Montine, J. Leverenz, K. Edwards, B. Cholerton (Seattle, WA, USA)
Predictive Ability of Clinical Timed Tests for Postural Instability and Gait Difficulty in Parkinson’s Disease

M. Bryant, J.-G. Hou, F. Jamal, G. Jackson, C. Workman, E. Protas (Houston, TX, USA)
Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)
Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.

N. Rocha, E. Furr-Stimming, A. Teixeira (Houston, TX, USA)
Predictors of cognitive impairment in multiple system atrophy

M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)
Predictors of onset of psychosis in Parkinson’s disease: “Who gets it early?”

P. Pal, A. Lenka, L. George, S. Arumugham, S. Hegde, N. Kamble, R. Yadav (Bangalore, India)
Predictors of Patient Satisfaction with Rechargeable Deep Brain Stimulator Implantable Pulse Generators

K. Mitchell, M. Volz, S. Wang, A. Lee, J. Ostrem (San Francisco, CA, USA)
Pregnancy and Parkinson’s disease: A review and update

M. Seier, A. Hiller (Portland, OR, USA)
Preliminary Report on the MAESTRO Study: A Pilot Study of Mirabegron and Behavioral Modification including Pelvic Floor Exercise for Overactive Bladder in Parkinson Disease.

S. Ray, D. Burdick, A. Griffith, P. Agarwal (Kirkland, WA, USA)
Preliminary results of 18F-DTBZ PET study in the patients with vascular parkinsonism

W.-Y. Lin, Y.-H. Weng, K.-J. Lin, C.-S. Lu (Taoyuan, Taiwan)
Premovement betaband event-related desynchronization related to simple lower limb movement and simulated gait initiation in Parkinson’s disease patients: MEG study

J.Y. Yun, J.S. Kim, H.W. Lee (Seoul, Republic of Korea)
Preoperative slowing of EEG and neurocognitive changes following subthalamic nucleus deep brain stimulation in Parkinson’s disease

Y. Higuchi, M. Yakufujiang, Y. Okahara, K. Aoyagi, M. Abe, T. Yamamoto, Y. Yamanaka, S. Hirano, Y. Iwadate (Chiba, Japan)
Prescription pattern of treatment in Mexican patients with Huntington’s Disease.

A. De-la-Cruz, L. Mendoza Vega, N. Davila Avila, K. Salinas Barboza, S. Isais Millan, A. Cervantes Arriaga, M. Rodriguez Violante (Ciudad de Mexico, Mexico)
Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy

K. Seppi, F. Krismer, G. Wenning, S. Papapetropoulos, V. Abler, W. Poewe (Innsbruck, Austria)
Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

O. Dogu, H. Kalegasi (Mersin, Turkey)
Prevalence of burning mouth syndrome in Parkinson disease

X.X. Yu, H. Fernandez (Cleveland, OH, USA)
Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)

H.-I. MA, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim (Anyang, Republic of Korea)
Prevalence of Restless Legs Syndrome in hemodialyzed patients

I. Estrada-Bellmann, S. Castillo-Torres, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías (Monterrey, Mexico)
Prevalence of substance abuse in Huntington´s disease patients and its relationship with neuropsychiatric symptoms

K. SALINAS BARBOZA, L. MENDOZA VEGA, A. CRUZ LANDERO, S. ISAIS MILLAN, M. RODRIGUEZ VIOLANTE, A. CERVANTES ARRIAGA, N. DAVILA AVILA (MEXICO, Mexico)
Prevalence of tremor in Multiple Sclerosis in Isfahan, Iran

M. Salari, M. Etemadifar, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)
Prevelance,clinical pathology and Treatment of Dystonia in Pakistani Population

S. Naureen, A. Arshad, N. Ahmad (RAWALPINDI, Pakistan)
Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease

K. Chung, B. Lobb (Portland, OR, USA)
Primary progressive apraxia: an unusual ideomotor syndrome

Y. Fernandez, S. Frucht (New York, NY, USA)
Prism adaptation and cerebellar inhibition were impaired in essential tremor

R. Hanajima, R. Tsutsumi, Y. Shirota, T. Shimizu, N. Tanaka, Y. Ugawa (Kanagawa, Japan)
Pro-saccades predict decline in attention over 18months in newly diagnosed Parkinson’s disease

S. Stuart, L. Alcock, J. Nell, R. Lawson, R. Morris, A. Yarnall, D. Burn, L. Rochester (Newcastle Upon Tyne, United Kingdom)
Probabilistic mapping of deep brain stimulation in Parkinson’s disease.

T. Dembek, J. Roediger, V. Visser-Vandewalle, L. Timmermann, M. Barbe (Cologne, Germany)
Probiotic correction of intestinal dysbiosis in Parkinson’s disease

I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)
Prof. Wadia’s contributions to neurology and SCA2

F. Tensini, J. Pedroso, O. Barsottini, H. Teive (Curiitiba, Brazil)
Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

T. Farombi, A. Ogunniyi (Ibadan, Nigeria)
Profound reduction of DAT-SPECT signal in multiple system atrophy (MSA)

I. Toyoshima, T. Hatakeyama, E. Abe, C. Wada, M. Kobayashi, K. Obara (Yurihonjo, Japan)
Prognosis and end-of-life status after emergency admissions in patients with Parkinson disease: a Japanese single center retrospective study

K. Ikeda, K. Takahashi, K. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Araki, T. Yamamoto (Iruma-gun, Saitama-ken, Japan)
Prognostic relevance and predictive ability of data-driven PD subtypes in the Longitudinal and Biomarker Studies in Parkinson’s disease (LABS-PD)

T. Mestre, S. Eberly, C. Tanner, D. Grimes, A. Lang, D. Oakes, C. Marras (Ottawa, ON, Canada)
Programming deep brain stimulation in the globus pallidus internus for treatment of idiopathic Parkinson’s disease: experience at the University of Kentucky

J. Gurwell, J. Quintero, J. Lamm, J. Slevin, G. Gerhardt, C. van Horne (Lexington, KY, USA)
Programming of deep brain stimulators in Parkinson’s disease with early motor complications (EARLYSTIM-study)

K. Knudsen, J.-L. Houeto, P. Krack, J. Rau, C. Schade-Brittinger, A. Schnitzler, W.M.M. Schuepbach, L. Timmermann, L. Tonder, G. Deuschl (Kiel, Germany)
Progression of milestones by clinical types in progressive supranuclear palsy: a longitudinal observational study of a cohort of patients with PSP/CBD (the JALPAC project)

I. Aiba, T. Ikeuchi, H. Takigawa, T. Shimohata, T. Tokuda, M. Morita, O. Onodera, S. Murayama, K. Hasegawa, K. Nakashima (Nagoya, Japan)
Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging

J. Infante, M. Sierra, I. Martínez-Rodríguez, P. Sánchjez-Juan, I. González-Aramburu, M. Jimenez-Alonso, A. Sánchez-Rodriguez, I. Banzo (Santander, Spain)
Progressive ataxia and palatal tremor: 2 autopsy cases of a novel tauopathy

A. Gao, A. Faust-Socher, M. Del Bigio, A. Lang, D. Munoz (Toronto, ON, Canada)
Progressive microstructural abnormalities of the occipital cortex in Huntington’s disease

O. Odish, R. Reijntjes, S. van_den Bogaard, R. Roos, A. Leemans (Leiden, Netherlands)
Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)
Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)
PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events

M. Schuberth, J. Levin, S. Maaß, G. Respondek, K. Bötzel, G. Höglinger (Muenchen, Germany)
Prominent extensor truncal and cervical dystonia induced by mirtazapine

W.T. Yoon (Seoul, Republic of Korea)
Proprioceptive Focal Stimulation (Equistasi®) may improve gait in severe Parkinson’s disease patients. Gait Analysis double-blind, double-dummy randomized study

A. Peppe, S. Paravati, g. Chini, P. Paone (Roma, Italy)
Prospective Analysis of Morphological Markers of Development of Impulsive Compulsive Behaviors in De Novo Parkinson’s Disease

L. Ricciardi, C. Lambert, R. De Micco, F. Morgante, M. Edwards (London, United Kingdom)
Prospective longitudinal CSF measurements and cognitive decline in GBA-associated Parkinsonism: not Abeta or Tau but Lewy body pathology?

S. Lerche, C. Schulte, K. Srulijes, A. Pilotto, T. Rattay, A.-K. Hauser, E. Stransky, C. Deuschle, I. Csoti, H. Zetterberg, I. Liepelt-Scarfone, T. Gasser, W. Maetzler, D. Berg, K. Brockmann (Tübingen, Germany)
Protective effect of Myristicin against neurodegeneration in a 6-hydroxydopamine induced model of Parkinson’s disease in rats

A. Morad Ganjeh (Karaj, Islamic Republic of Iran)
Protocol for upper-limb kinematic analysis in paediatric movement disorders and relative normality data

L. Garavaglia, E. Pagliano, A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)
Psychiatric comorbidities are common in patients with Orthostatic Tremor

D. Bhatti, R. Thompson, K. Malgireddy, B. Bayer, D. Bessette, M. Fleisher, D. Murman, D. Torres-Russotto (Omaha, NE, USA)
Psychiatric Manifestations of Neuroacanthocytosis Syndromes

Z. Brahem, i. bedoui, a. riahi, h. derbali, m. mansour, j. zaouali, r. mrissa (Tunis, Tunisia)
Psycho-behavioral profile of Parkinson’s disease patients with RLS: a cross sectional-study

A. MARQUES, M. Figorilli, B. Pereira, P. Derost, B. Debilly, P. Beudin, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)
Psychogenic abdominal myoclonus in Pregnancy: Case Report

D. García, P.O. Vargaz, Z. Lopez (Toluca de Lerdo, Mexico)
Psychological distress among caregivers of Parkinson’s patients assessed with the SCL-90-R self-reported questionnaire

B. Ozdilek, S. Bozkurt Zincir, D. Ince Gunal (Istanbul, Turkey)
Psychosocial evaluation in caregivers of patients with Parkinson’s disease: analysis of a cohort of Rio de Janeiro / Brazil

V. Carvalho Neri, C. Teixeira Muratori, P. Portes Ferreira, P. Sandin, G. Licassali, S. Barbosa Gomes, E. Reynaldo (Campos dos Goytacazes, Brazil)
Psychosocial Impact of X-Linked Dystonia Parkinsonism (XDP) of Panay

J.N. Ong, C. Go, G. Solinap, P. Acuna (Manila, Philippines)
Pure ATXN10 repeat expansion causes Parkinson’s disease

F. Jimenez Gil, K. McFarland, K. Lee, Y.-C. Tsai, C. Byrne, R. Gopi, N. Huang, J. Langston, T. Clark, T. Ashizawa, B. Schuele (Guadalajara, Jalisco, Mexico)
Putaminal Atrophy Gradient in X-linked Dystonia-Parkinsonism

H. Hanßen, M. Heldmann, C. Diesta, R. Rosales, A. Domingo, T. Münte, C. Klein, N. Brüggemann (Luebeck, Germany)
Putaminal Diffusion Imaging for the Differential Diagnosis of the Parkinsonian Variant of Multiple System Atrophy from Parkinson’s Disease: Impact of Segmentation Accuracy

R. De Marzi, S. Bajaj, F. Krismer, B. Larcher, S. Ringler, G. Wenning, M. Schocke, W. Poewe, K. Seppi (Innsbruck, Austria)